Purification of the fourth, second and fifth components of mouse complement.

Por Fukuoka, Y, Seino, J, Okuda, T, Tachibana, T
Publicado em 1984

Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a

Por FUKUOKA, Y, STRAINIC, M, MEDOF, M E
Publicado em 2003

Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.

Por Ikeda, Y, Fukuoka, Y, Motomura, K, Yasuda, T, Nishino, T
Publicado em 1990

In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.

Por Fukuoka, Y, Ikeda, Y, Yamashiro, Y, Takahata, M, Todo, Y, Narita, H
Publicado em 1993

Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies

Por Ito, M R, Terasaki, S, Kondo, E, Shiwaku, H, Fukuoka, Y, Nose, M
Publicado em 2000

Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Por Sun, J., Ember, J. A., Chao, T. H., Fukuoka, Y., Ye, R. D., Hugli, T. E.
Publicado em 1999

Interactions of beta-lactam antibiotics and antineoplastic agents.

Por Ueda, Y, Saito, A, Fukuoka, Y, Yamashiro, Y, Ikeda, Y, Taki, H, Yasuda, T, Saikawa, I
Publicado em 1983

In Vitro and In Vivo Antibacterial Activity of T-1220, a New Semisynthetic Penicillin

Por Ueo, K., Fukuoka, Y., Hayashi, T., Yasuda, T., Taki, H., Tai, M., Watanabe, Y., Saikawa, I., Mitsuhashi, S.
Publicado em 1977

Preliminary evidence supports circulating microRNAs as prognostic biomarkers for type 2 diabetes

Por Flowers, E., Kanaya, A. M., Fukuoka, Y., Allen, I. E., Cooper, B., Aouizerat, B. E.
Publicado no Obes Sci Pract (2017)

In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

Por Tai, M, Fukuoka, Y, Yotsuji, A, Kumano, K, Takahata, M, Mikami, H, Yasuda, T, Saikawa, I, Mitsuhashi, S
Publicado em 1982